Please use this identifier to cite or link to this item:
https://hdl.handle.net/10216/165667Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.creator | Carneiro, P | - |
| dc.creator | Vicente, MM | - |
| dc.creator | Leite, MI | - |
| dc.creator | Santos, ME | - |
| dc.creator | Pinho, SS | - |
| dc.creator | Fernandes, Â | - |
| dc.date.accessioned | 2025-03-10T14:08:52Z | - |
| dc.date.available | 2025-03-10T14:08:52Z | - |
| dc.date.issued | 2025 | - |
| dc.identifier.issn | 1568-9972 | - |
| dc.identifier.uri | https://hdl.handle.net/10216/165667 | - |
| dc.description.abstract | Regulatory T cells (Tregs) have a key role in the maintenance of immune tolerance and in the prevention of autoimmunity. Recent studies have shown an association between decreased Treg frequency and a deficient suppressive activity with the development of many autoimmune diseases. Although glycosylation, which consists in the addition of glycans to proteins and lipids on the cell surface, is recognized as a critical modification for T cell development and function, the relevance of glycans in Treg biology and activity, as well as their impact in the immunopathogenesis of autoimmune diseases, deserves more attention, as it is far from being fully understood. This review discusses the biological impact of N-glycans in Treg biology, highlighting their potential to uncover novel pathogenic mechanisms in autoimmunity and new targets for promising therapeutic approaches with clinical applications in autoimmune disease patients. | pt_PT |
| dc.description.sponsorship | ÂF acknowledges FCT (Portuguese Foundation for Science and Technology) for funding (Grant: 2022.01422.PTDC); Portuguese Society of Neurology (SPN) – (Grant: Bolsa Pereira Monteiro); and PARSUK/ FCT/British Embassy Lisbon - UK Science and Innovation Network (Grant: PARSUK Bilateral Research Fund). SSP also acknowledges funding by “2022 LRA Lupus Innovation Award”, and by “European Crohn's and Colitis Organisation (ECCO) Pioneer Award 2021”. Co- funded by the European Union (ERC, GlycanSwitch, 101071386). Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or the European Research Council Executive Agency. Neither the European Union nor the granting authority can be held responsible for them. | - |
| dc.language.iso | eng | pt_PT |
| dc.publisher | Elsevier | pt_PT |
| dc.relation.ispartofseries | Autoimmunity reviews, vol. 24(6):103791 | pt_PT |
| dc.rights | openAccess | pt_PT |
| dc.rights.uri | https://creativecommons.org/licenses/by/4.0/ | - |
| dc.subject | Autoimmune disorders | pt_PT |
| dc.subject | Autoimmunity | pt_PT |
| dc.subject | N-glycosylation | pt_PT |
| dc.subject | Regulatory T cells | pt_PT |
| dc.title | The role of N-glycans in regulatory T cells in autoimmunity | pt_PT |
| dc.type | Artigo em Revista Científica Internacional | pt_PT |
| dc.collection | - | |
| dc.contributor.uporto | Instituto de Investigação e Inovação em Saúde | pt_PT |
| dc.identifier.doi | 10.1016/j.autrev.2025.103791 | - |
| dc.relation.publisherversion | https://www.sciencedirect.com/science/article/pii/S1568997225000515?via%3Dihub | - |
| Appears in Collections: | I3S - Artigo em Revista Científica Internacional | |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| 10.1016-j.autrev.2025.103791.pdf | 976.08 kB | Adobe PDF | ![]() View/Open |
This item is licensed under a Creative Commons License
